Skip to main content
Fig. 5 | Diagnostic Pathology

Fig. 5

From: Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma

Fig. 5

Relationship between ORR (per RECIST v1.1 per investigator) and tumor membrane score (logistic regression). *Based on N = 155 NSCLC patients enrolled prior to enrichment. CI confidence interval, NSCLC non-small cell lung cancer, ORR objective response rate, RECIST Response Evaluation Criteria In Solid Tumors

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us